b-Arrestins in the Immune System - Progress in Molecular Biology and Translational Science - page 380

111. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and
TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat
Immunol . 2006;7:139 - 147.
112. Porter KJ, Gonipeta B, Parvataneni S, et al. Regulation of lipopolysaccharide-induced
inflammatory response and endotoxemia by beta-arrestins. J Cell Physiol .

2010;225:406- 416.
113. Fan H, Luttrell LM, Tempel GE, Senn JJ, Halushka PV, Cook JA. Beta-arrestins 1 and 2
differentially regulate LPS-induced signaling and pro-inflammatory gene expression.
Mol Immunol . 2007;44:3092- 3099.
114. Seregin SS, Appledorn DM, Patial S, et al. beta-Arrestins modulate Adenovirus-
vector-induced innate immune responses: differential regulation by beta-arrestin-1
and beta-arrestin-2. Virus Res . 2010;147:123 - 134.
115. Li H, Sun X, LeSage G, et al. b -Arrestin 2 regulates Toll-like receptor 4-mediated
apoptotic signalling through glycogen synthase kinase-3beta. Immunology . 2010;130:
556 - 563.
116. Li H, Chen L, Zhang Y, et al. Chronic stress promotes lymphocyte reduction through
TLR2 mediated PI3K signaling in a beta-arrestin 2 dependent manner. J Neuroimmunol .
2011;233:73 - 79.
117. Husebye H, Halaas O, Stenmark H, et al. Endocytic pathways regulate Toll-like recep-
tor 4 signaling and link innate and adaptive immunity. EMBO J . 2006;25:683- 692.
118. Parameswaran N, Pao CS, Leonhard KS, et al. Arrestin-2 and G protein-coupled
receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate
lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J Biol Chem .

2006;281:34159 - 34170.
119. TippingM, KimY, Kyriakakis P, Tong M, Shvartsman SY, Veraksa A. b -arrestin Kurtz
inhibits MAPK and Toll signalling in Drosophila development. EMBO J .

2010;29:3222- 3235.
120. Wang W, Xu M, Zhang YY, He B. Fenoterol, a beta(2)-adrenoceptor agonist, inhibits
LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory
cytokines production through beta-arrestin-2 in THP-1 cell line. Acta Pharmacol Sin .
2009;30:1522- 1528.
121. Kizaki T, Shirato K, Sakurai T, et al. Beta2-adrenergic receptor regulate Toll-like
receptor 4-induced late-phase NF-kappaB activation. Mol Immunol . 2009;46:

1195- 1203.
122. Fox JM, Letellier E, Oliphant CJ, Signoret N. TLR2-dependent pathway of heterol-
ogous down-modulation for the CC chemokine receptors 1, 2, and 5 in human blood
monocytes. Blood . 2011;117:1851 - 1860.
123. Zhuang LN, Hu WX, Xin SM, Zhao J, Pei G. Beta-arrestin-1 protein represses
adipogenesis and inflammatory responses through its interaction with peroxisome
proliferator-activated receptor-gamma (PPARgamma).

J Biol Chem . 2011;286:

28403 - 28413.
124. Gao H, Sun Y, Wu Y, et al. Identification of beta-arrestin2 as a G protein-coupled
receptor-stimulated regulator of NF-kappaB pathways. Mol Cell . 2004;14:303 - 317.
125. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. beta-Arrestin inhibits
NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor
IkappaBalpha. Proc Natl Acad Sci USA . 2004;101:8603 - 8607.
126. Kawamata Y, Imamura T, Babendure JL, Lu JC, Yoshizaki T, Olefsky JM. Tumor
necrosis factor receptor-1 can function through a G alpha q/11-beta-arrestin-1 signal-
ing complex. J Biol Chem . 2007;282:28549 - 28556.
127. Mo W, Zhang L, Yang G, et al. Nuclear beta-arrestin1 functions as a scaffold for the
dephosphorylation of STAT1 and moderates the antiviral activity of IFN-gamma. Mol
Cell . 2008;31:695 - 707.